Rigel Pharmaceuticals, Inc.

NASDAQ:RIGL

27.22 (USD) • At close November 12, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999
Operating Activities:
Net Income -25.091-58.573-17.914-29.744-66.894-70.48-77.992-69.216-51.464-90.908-89.027-98.84-85.97337.89-111.547-132.346-74.272-37.637-45.256-56.255-41.197-37.03-23.805-25.36-12.366
Depreciation & Amortization 1.2380.9981.1620.7060.6830.5940.4650.9411.4392.3592.5922.4331.9551.3171.4031.4251.3441.4181.182.3733.1775.8246.767.5571.906
Deferred Income Tax -10.57600.287000-1.0820.0270-0.0980085.973000-11.687-12.579-0.03-0.127-0.513-0.956-2.633-2.730
Stock Based Compensation 8.80612.3859.4867.2979.1157.7045.9877.3337.4039.7877.16612.61713.16816.43613.438011.68712.5790.030.1270.5130.9562.6334.880
Change In Working Capital 9.517-29.0499.718-30.32216.6594.122-5.43-15.79219.266-0.195-6.792-1.4021.475-8.9-6.0733.6449.034-12.19611.02613.2614.663-3.1461.574-1.2150.931
Accounts Receivables 9.77-24.8480.501-5.862-6.034-4.07700.2035.5470-5.75000001.104-0.054-1.050.50.349-0.35-0.491.6850
Inventory 1.172-2.377-4.875-0.126-0.366-0.83902.0920.80101.366000001.7571.344-107.425-50.627-35.663-26.769-24.945-49.9580
Accounts Payables -0.3663.7880.041-0.331-2.2393.755-2.9472.81.15-2.292.2060.1410.153-1.751-2.8302.363-0.540.5520.567-2.0821.480.6380.4310
Other Working Capital -1.059-5.61214.051-24.00325.2985.283-2.483-20.88711.7682.095-4.614-1.5431.322-7.149-3.2433.6443.81-12.946118.94962.82142.05922.49326.37146.6270.931
Other Non Cash Items 10.3630.4813.139-0.122-1.073-0.7660.4950.818-0.0579.3022.1911.198-85.9730023.75911.68712.579-2.122.4690.917-0.176-0.515.281.698
Operating Cash Flow -5.743-73.7585.878-52.185-41.51-58.826-77.557-75.889-23.413-69.753-86.061-85.192-69.37546.743-102.779-103.518-52.207-35.836-35.17-38.152-32.44-34.528-15.981-11.588-7.831
Investing Activities:
Investments In Property Plant And Equipment -15-0.45-0.627-1.262-1.455-1.106-0.164-0.804-0.546-0.413-1.221-3.377-2.303-3.56-0.141-2.507-0.933-0.913-1.794-1.545-1.242-1.635-3.229-3.617-7.086
Acquisitions Net 0.2590.8930.6271.2621.4551.1060.7320.0880.0601.2213.3772.3033.560.141000000-24.964000
Purchases Of Investments -31.206-28.894-141.459-81.706-145.327-77.996-116.861-103.053-151.763-218.594-308.846-475.398-476.038-266.092-169.928-194.603-134.372-85.209-89.584-96.436-42.135-26.713-47.511-3.9620
Sales Maturities Of Investments 41.65101.22862.05130.434123.126104.06696.82128.65196.862281.705382.447439.724415.493216.249139.391170.122127.50889.98789.22772.176647.83929.5900
Other Investing Activites -4.29773.227-0.627-1.262-1.455-1.1060.7320.0880.060.234-1.221-3.377-2.303-3.56-0.1270.0180.0040.083000.07124.964000
Investing Cash Flow -4.29772.777-80.03647.466-23.65624.964-19.47324.88144.61362.93272.38-39.051-62.848-53.403-30.664-26.97-7.7933.948-2.151-25.805-37.30619.491-21.15-7.579-7.086
Financing Activities:
Debt Repayment 0000000000000000000000000
Common Stock Issued 1.0492.1244.7752.5961.57671.894114.1823.5865.2921.171.051139.094142.7791.964103.603130.37257.3532.793103.50566.22454.6231.7970.88861.3025.979
Common Stock Repurchased 0000000000000000000000000
Dividends Paid 0000000000000000000000000
Other Financing Activities 34.6368.85262.67519.9519.57871.8943.5081.5981.7611.171.051139.09400-1.4481.618-0.5770.0430.1-1.393-1.788-1.713-1.2991.0595.281
Financing Cash Flow 18.3676.5562.67512.57111.36571.894117.68825.1847.0531.171.051139.094141.9790.82102.155131.9956.7762.836103.60564.83152.83230.084-0.41162.36111.26
Other Information:
Effect Of Forex Changes On Cash 0000000000000000000000000
Net Change In Cash 8.3275.569-11.4837.852-53.80138.03220.658-25.82428.253-5.651-12.6314.8519.756-5.84-31.2881.502-3.224-29.05266.2840.874-16.91415.047-37.54243.194-3.657
Cash At End Of Period 32.78624.45918.8930.37322.52176.32238.2917.63243.45615.20320.85433.48418.6338.87714.71746.00544.50347.72776.77910.4959.62126.53511.48849.035.836